Skip to content

ADPT

Adaptive Biotechnologies Corporation

Stock

$28.35+0.98 (+3.58%)Close Oct 2, 2026

Revenue, 2025
$277M
YoY, 2025
+54.8%
5-year CAGR
+23.0%

Revenue

Revenue by fiscal year

PeriodRevenueYoY
2025$277M+54.8%
2024$179M+5.1%
2023$170M−8.1%
2022$185M+20.1%
2021$154M+56.9%
2020$98M+15.6%
2019$85M+52.8%
2018$56M+44.8%
2017$38M—